A Study to Evaluate the Efficacy and Safety of Autogene Cevumeran (RO7198457) in Combination With Pembrolizumab Versus Pembrolizumab Alone in Participants With Previously Untreated Advanced Melanoma.
PHASE2
This study will evaluate the efficacy, safety, pharmacokinetics, and patien...
A Study of the Efficacy and Safety of RO7198457 in Combination With Atezolizumab Versus Atezolizumab Alone Following Adjuvant Platinum-Doublet Chemotherapy in Participants Who Are ctDNA Positive After Surgical Resection of Stage II-III Non-Small Cell Lung Cancer
PHASE2
This study will evaluate the efficacy, safety, pharmacokinetics, immunogeni...
A Study of Autogene Cevumeran (RO7198457) as a Single Agent and in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic Tumors
PHASE1
This is a Phase 1a/1b, open-label, multicenter, global, dose-escalation stu...
A Phase II Clinical Trial Comparing the Efficacy of RO7198457 Versus Watchful Waiting in Patients With ctDNA-positive, Resected Stage II (High Risk) and Stage III Colorectal Cancer
PHASE2
This is a multi-site, open-label, Phase II, randomized, trial to compare th...
A Study to Evaluate the Efficacy and Safety of Autogene Cevumeran With Nivolumab Versus Nivolumab Alone in Participants With High-risk Muscle-invasive Urothelial Carcinoma (MIUC)
PHASE2
The original purpose of this study was to evaluate the efficacy of adjuvant...
Status
Active Not Recruiting
Location
Memorial Sloan Kettering Cancer Center Basking Ridge